Saeedi P,Petersohn I,Salpea P,Malanda B,Karuranga S,Unwin N .2019 .Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 157 : 107843.
Teixeira-Lemos E,Nunes S,Teixeira F .2011 .Regular physical exercise training assists in preventing type 2 diabetes develop ment: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol, 10 : 12.
Berbudi A,Rahmadika N,Tjahjadi AI,Ruslami R .2020 .Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev, 16 : 442-9.
Wrighton K.H.,Lin X.,Feng X.H. .2009 .Phospho-control of TGFbeta superfamily signaling. Cell Res, 19(1) : 8-20.
WHO .2017 .Diabetes fact sheet. , : .
Giacco F,Brownlee M. . .Oxidative stress and diabetic complications. 2010 Oct, 10(9) : PMC2996922-70.
Shaker YM,Soliman HA,Ezzat E,Hussein NS,Ashour E,Donia A,Eweida SM . .Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients. , : .
Beni-Suef Univ J Basic Appl Sci .2014 .. , 3(1) : .
Jeon YL,Kim MH,Lee WI,Kang SY . .Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.. , : .
Lab Clin .2013 .. , 24409655 : 1221-9.
Hills CE,Squires PE .2011 .The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine & Growth Factor Reviews, : .
Santibañez M.,Quintanilla C.,Bernabeu C. .2011 .TGFβ/TGF-β receptor system and its role in physiological and pathological conditions. Clinical Science, 121(6) : 233-251.
Pelton R.W. .1991 .Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol, 115(4) : 1091-105.
Hills C.E. and P.E.,Squires C.E. and P.E. .2010 .TGF-beta1-induced epithelial-tomesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol, 31(1) : 68-74.
Sharma K.,Ziyadeh F.N. .1997 .Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol, 17(2) : 80-92.
Wang W.,Koka V.,Lan H.Y. .2005 .Transforming growth factorbeta and Smad signalling in kidney diseases. Nephrology (Carlton), 10(1) : 48-56.
Sureshbabu A,Muhsin SA,Choi ME .2015 .Epub 2016 Jan 6. Am J Physiol Renal Physiol. 2016 Apr, 10(7) : PMC4824143-F606.